- Home
- SIGI vs DYN Comparison
SIGI vs DYN Comparison
Compare SIGI & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SIGI | DYN |
|---|---|---|
| Founded | 1926 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.8B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SIGI | DYN |
|---|---|---|
| Price | $87.12 | $18.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $85.80 | $37.00 |
| AVG Volume (30 Days) | 276.1K | ★ 2.7M |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.03% | N/A |
| EPS Growth | ★ 131.89 | N/A |
| EPS | ★ 3.69 | N/A |
| Revenue | ★ $5,336,928,000.00 | N/A |
| Revenue This Year | $0.41 | N/A |
| Revenue Next Year | $4.81 | N/A |
| P/E Ratio | $24.05 | ★ N/A |
| Revenue Growth | ★ 9.78 | N/A |
| 52 Week Low | $72.78 | $11.92 |
| 52 Week High | $100.40 | $27.31 |
Technical Indicators
Market Signals| Indicator | SIGI | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 36.53 | 19.18 |
| Support Level | $81.10 | $16.55 |
| Resistance Level | $91.48 | $19.54 |
| Average True Range (ATR) | 1.69 | 1.10 |
| MACD | -0.21 | -0.82 |
| Stochastic Oscillator | 16.17 | 6.30 |
Price Performance
Historical ComparisonAbout SIGI Selective Insurance Group Inc.
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.